BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33631356)

  • 21. Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care.
    Dela Cruz AM; Walker R; Pipes R; Wakhlu S; Trivedi MH
    Addict Sci Clin Pract; 2021 Feb; 16(1):12. PubMed ID: 33608060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
    Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrating peer support services into primary care-based OUD treatment: Lessons from the Penn integrated model.
    Harris RA; Campbell K; Calderbank T; Dooley P; Aspero H; Maginnis J; O'Donnell N; Coviello D; French R; Bao Y; Mandell DS; Bogner HR; Lowenstein M
    Healthc (Amst); 2022 Sep; 10(3):100641. PubMed ID: 35785613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bridging Recovery Initiative Despite Gaps in Entry (BRIDGE): study protocol for a randomized controlled trial of a bridge clinic compared with usual care for patients with opioid use disorder.
    Marcovitz DE; White KD; Sullivan W; Limper HM; Dear ML; Buie R; Edwards DA; Chastain C; Kast KA; Lindsell CJ;
    Trials; 2021 Oct; 22(1):757. PubMed ID: 34717736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expanding Opioid Use Disorder Treatment in Priority Areas: The Role of Certified Nurse-Midwives.
    Kane C; Topmiller M
    J Midwifery Womens Health; 2022 May; 67(3):314-320. PubMed ID: 35506768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of opioid use disorder in primary care.
    Buresh M; Stern R; Rastegar D
    BMJ; 2021 May; 373():n784. PubMed ID: 34011512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posttraumatic stress disorder in individuals seeking treatment for opioid use disorder in Vermont.
    Peck KR; Moxley-Kelly N; Badger GJ; Sigmon SC
    Prev Med; 2021 Nov; 152(Pt 2):106817. PubMed ID: 34599919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems.
    Boudreau DM; Lapham G; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Campbell CI; Rossom RC; Binswanger IA; Yarborough BJ; Arnsten JH; Cunningham CO; Glass JE; Murphy MT; Zare M; Hechter RC; Ahmedani B; Braciszewski JM; Horigian VE; Szapocznik J; Samet JH; Saxon AJ; Schwartz RP; Bradley KA
    J Subst Abuse Treat; 2020 Mar; 112S():41-48. PubMed ID: 32220410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol.
    Bryan MA; Smid MC; Cheng M; Fortenberry KT; Kenney A; Muniyappa B; Pendergrass D; Gordon AJ; Cochran G
    Addict Sci Clin Pract; 2020 Oct; 15(1):33. PubMed ID: 33129355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs.
    Scott TM; Arnsten J; Olsen JP; Arias F; Cunningham CO; Rivera Mindt M
    Addict Sci Clin Pract; 2021 Oct; 16(1):64. PubMed ID: 34689841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of a Multimodal Educational Intervention for Primary Care Physicians With Prescriptions of Buprenorphine for Opioid Use Disorders.
    Clark B; Kai M; Dix R; White J; Rozenfeld Y; Levy S; Engstrom K
    JAMA Netw Open; 2019 Oct; 2(10):e1913818. PubMed ID: 31642929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers.
    Calcaterra SL; Lockhart S; Callister C; Hoover K; Binswanger IA
    J Gen Intern Med; 2022 Aug; 37(11):2786-2794. PubMed ID: 34981359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blended smartphone intervention for patients in opioid maintenance treatment in Iran: protocol for a randomized controlled trial.
    Boumparis N; Noroozi A; Naghizadeh E; Meyer A; Wenger A; Rahimi-Movaghar A; Schaub MP
    BMC Psychiatry; 2023 Jul; 23(1):518. PubMed ID: 37464337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems.
    Bagley SM; Chavez L; Braciszewski JM; Akolsile M; Boudreau DM; Lapham G; Campbell CI; Bart G; Yarborough BJH; Samet JH; Saxon AJ; Rossom RC; Binswanger IA; Murphy MT; Glass JE; Bradley KA;
    Addict Sci Clin Pract; 2021 Jul; 16(1):46. PubMed ID: 34233750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update.
    Andrilla CHA; Moore TE; Patterson DG; Larson EH
    J Rural Health; 2019 Jan; 35(1):108-112. PubMed ID: 29923637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The case for a medication first approach to the treatment of opioid use disorder.
    Winograd RP; Presnall N; Stringfellow E; Wood C; Horn P; Duello A; Green L; Rudder T
    Am J Drug Alcohol Abuse; 2019; 45(4):333-340. PubMed ID: 31084515
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment Outcomes Among Black Adults Receiving Medication for Opioid Use Disorder.
    Parlier-Ahmad AB; Pugh M; Martin CE
    J Racial Ethn Health Disparities; 2022 Aug; 9(4):1557-1567. PubMed ID: 34254271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective?
    Marsden J; Tai B; Ali R; Hu L; Rush AJ; Volkow N
    Addiction; 2019 Aug; 114(8):1346-1353. PubMed ID: 30614096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.
    Cole ES; DiDomenico E; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kim JY; Kmiec J; Kelley D; Donohue JM
    J Gen Intern Med; 2019 Jun; 34(6):936-943. PubMed ID: 30887440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial.
    Ellerbroek H; van den Heuvel SAS; Dahan A; Timmerman H; Kramers C; Schellekens AFA
    Addict Sci Clin Pract; 2022 Sep; 17(1):47. PubMed ID: 36057608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.